EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 168 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $42,580,000 | 6.66% |
| Stonepine Capital Management, LLC | 329,130 | $3,344,000 | 1.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $3,048,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 381,145 | $3,872,000 | 1.40% |
| Samsara BioCapital, LLC | 450,000 | $4,572,000 | 0.84% |
| Altium Capital Management LP | 289,316 | $2,939,000 | 0.82% |
| VR Adviser, LLC | 700,000 | $7,112,000 | 0.77% |
| Corriente Advisors, LLC | 200,000 | $2,032,000 | 0.75% |
| RA Capital Management | 1,250,000 | $12,700,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,181,200 | $12,001,000 | 0.18% |